Skip to main content
. Author manuscript; available in PMC: 2015 Aug 13.
Published in final edited form as: Cochrane Database Syst Rev. 2014 Aug 13;8:CD003256. doi: 10.1002/14651858.CD003256.pub2

Data and Analyses.

Comparison 1. HAART + ABV versus HAART alone (RCT)
Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2 Progressive disease 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.1 [0.01, 0.75]
3 Clinical response 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
 3.1 Complete response 1 100 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.64, 6.22]
 3.2 Partial response 1 100 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [1.01, 2.91]
 3.3 Stable disease 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.06 [0.00, 0.99]
 3.4 Overall response (complete and partial) 1 100 Risk Ratio (M-H, Fixed, 95% CI) 1.78 [1.16, 2.72]
4 Adverse events 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.59, 1.32]